- AU$11.43m
- AU$17.21m
- AU$7.47m
Australia Stock Exchange release from RHINOMED : App 3Y RD
Brief: Rhinomed Says HY Loss After Income Tax Expense Attributable A$3.2 Mln
Australia Stock Exchange release from RHINOMED : Half Yearly Report and Accounts
Australia Stock Exchange release from RHINOMED : PRE_NR Ends: 13:17:09
Australia Stock Exchange release from RHINOMED : Rhinomed half year results - 31 December 2021
Australia Stock Exchange release from RHINOMED : R & D refund
Australia Stock Exchange release from RHINOMED : Corporate Governance Statement
Australia Stock Exchange release from RHINOMED : Appendix 4G
Australia Stock Exchange release from RHINOMED : App 3Y JMcB
Australia Stock Exchange release from RHINOMED : App 3Y MJ
Australia's Rhinomed hits near 8-week high on upbeat quarterly revenue
Brief: Rhinomed Ltd Says Revenue For FY22 Q2 Was A$2.025 Mln, Up 17% On Previous Quarter
Australia Stock Exchange release from RHINOMED : Quarterly Activities/Appendix 4C Cash Flow Report
Australia Stock Exchange release from RHINOMED : PRE_NR Ends: 09:38:25
Australia Stock Exchange release from RHINOMED : Notification of cessation of securities - RNO
Australia Stock Exchange release from RHINOMED : App 3Y BS
Australia Stock Exchange release from RHINOMED : App 3Y EK
Australia's Rhinomed rises on positive clinical trial results
Australia Stock Exchange release from RHINOMED : Rhinoswab junior clinical trial results